Lv41
596 积分 2022-12-02 加入
Single cell multi-omics reveals re-dosing with CD3 bispecific antibody induces a TCF7 high central memory CD8 + T cell population associated with reduced cytokine production
6小时前
待确认
Neihulizumab (ALTB-168) in Patients with Steroid-Refractory Acute Graft-Versus-Host-Disease (SR-aGVHD) or Treatment-Refractory Acute Graft-Versus-Host-Disease (TR-aGVHD)
4个月前
已关闭
Neihulizumab (ALTB-168) in Patients with Steroid-Refractory Acute Graft-Versus-Host-Disease (SR-aGVHD) or Treatment-Refractory Acute Graft-Versus-Host-Disease (TR-aGVHD)
4个月前
已关闭
TSLP acts on regulatory T cells to maintain their identity and limit allergic inflammation
5个月前
已完结
Biopharma dealmaking in 2024
5个月前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
6个月前
已完结
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
6个月前
已完结
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
7个月前
已完结
Navigating the complexities of drug development for inflammatory bowel disease
7个月前
已完结
Inebilizumab for Treatment of IgG4-Related Disease
7个月前
已完结
皖公网安备34019202002308
